We have previously demonstrated that actively proliferating breast or prostate cancer cells stimulate osteoclast formation from RANKL‐primed precursors (Guo et al., 2008; Rafiei & Komarova, 2013; Tiedemann et al., 2009). This evidence concerns the gene TNFSF11 and prostate carcinoma.